CORINNIA WAGNER: Open Payments
NPI 1427444694 · FREDERICKSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,913 in 125 payments from 24 companies in 2025. Trend: 2023 $3,864 · 2024 $4,586 · 2025 $3,913
Food & beverage: $3,913
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 19 | $945 |
| GlaxoSmithKline, LLC. | 25 | $659 |
| ANI Pharmaceuticals, Inc. | 10 | $320 |
| Regeneron Healthcare Solutions, Inc. | 5 | $225 |
| Actelion Pharmaceuticals US, Inc. | 7 | $199 |
| Mallinckrodt Hospital Products Inc. | 3 | $189 |
| United Therapeutics Corporation | 4 | $168 |
| GENZYME CORPORATION | 7 | $167 |
| Pulmonx Corporation | 1 | $167 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $136 |
Products named: NUCALA, AIRSUPRA, DUPIXENT, PURIFIED CORTROPHIN GEL, TEZSPIRE, BREZTRI, ACTHAR, TRELEGY ELLIPTA.
Industry payments across VA — which companies pay providers there.
